Clinical Trial Update: 18F-FSPG PET/CT in Diagnosing Early Lung Cancer in Patients With Lung Nodules [Phase 2]

View source ↗

Summary

A Phase 2 trial evaluating 18F-FSPG PET/CT for diagnosing early lung cancer in patients with lung nodules has completed, with results posted in 2025.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Lung Cancer
• Pulmonary Nodules

Drugs mentioned

• 18F-FSPG PET/CT tracer (18F-FSPG)

Snippet

Sponsor: Andrei Iagaru | Conditions: Cigarette Smoker, Current Smoker | Phase 2 | Status: COMPLETED | Results posted: 2025-04-09